CUVCLINUVEL PHARMACEUTICALS LIMITEDMarket sensitive

Final EMA scientific advice for pivotal Phase III vitiligo

Date and time: 24 April 2026 at 6:56 pm
Announcement type: Company Update

Show details

Category: Other
Report codes: 11001
Sector: Health Care
Industry group: Pharmaceuticals, Biotechnology & Life Sciences

Recent CUV announcements